5 European Political Figures Linked to Brain-Enhancer and Drug Allegations: What the Evidence Shows in 2026

Explore five European political figures linked to drug allegations, viral misinformation, and public disclosures. Discover what the evidence reveals, the science behind brain enhancers and nootropics, and the risks of cognitive-enhancement substances in 2026.

Introduction: Brain Enhancers, Political Scandals and the Search for Evidence


The pressure to remain alert, make rapid decisions and perform under scrutiny is familiar to people in government. Political leaders routinely face demanding schedules, international negotiations, long flights and high-stakes decisions. That reality has helped fuel public curiosity about whether politicians use substances to improve concentration, increase wakefulness or maintain their energy.

The topic is often discussed under the broad label of brain enhancers, a term that can refer to prescription medicines, caffeine, dietary supplements, experimental compounds and substances promoted as nootropics. But the terminology can be misleading. A product marketed to improve memory is not necessarily effective, a medicine prescribed for a medical condition is not automatically a performance-enhancing drug, and an allegation of illegal drug use is not evidence that someone used a cognitive enhancer.

In European politics, these distinctions have become particularly important as social media clips and edited images circulate faster than fact-checkers can examine them. In May 2025, a small white object on a train table became the centre of a viral claim that French President Emmanuel Macron, German Chancellor Friedrich Merz and British Prime Minister Keir Starmer had been caught with cocaine. High-resolution photographs showed that the object was a tissue, and fact-checkers found no credible evidence supporting the accusation.

Other cases involve different circumstances. Ukrainian President Volodymyr Zelenskyy has been targeted by manipulated videos falsely suggesting cocaine use. Former Greek finance minister Yanis Varoufakis, by contrast, openly discussed taking ecstasy during an experience in Australia in 1989. In 2026, his remarks prompted a legal investigation in Greece into whether his comments could constitute an offence related to promoting drug use. That investigation concerns his statements, not proof that he used brain-enhancing drugs while holding public office.

This article examines five political figures whose names have been connected to drug-related claims or disclosures. It also explains what cognitive enhancers are, what science says about them, why plant-based nootropics attract attention, and how readers can separate credible reporting from political misinformation.

An important distinction: The available evidence does not establish that these five people used nootropics to enhance their political performance. The cases below are included because they illustrate different kinds of drug-related allegations, public disclosures and misinformation—not because they represent five proven cases of brain-enhancer use.

1. Emmanuel Macron: How a Tissue Became a Viral Cocaine Allegation


French President Emmanuel Macron became the subject of a widely circulated drug allegation in May 2025 after a short video from a diplomatic journey to Ukraine spread across social media.

The footage showed Macron sitting at a table on a train with German Chancellor Friedrich Merz and British Prime Minister Keir Starmer. A small white object was visible on the table. When Macron picked it up, some online commentators claimed it was a packet of cocaine. The allegation quickly expanded into claims that the leaders had been caught using drugs before meeting Ukrainian President Volodymyr Zelenskyy.

The story spread widely, but its central claim did not withstand examination.

What did the evidence show?

The original footage was not sufficiently detailed to identify the object with certainty. However, higher-resolution photographs from the Associated Press and other news coverage showed an object consistent with a crumpled tissue. The French presidential office also said that the object was a tissue used for blowing one’s nose.

PolitiFact examined the claim in its May 13, 2025, fact-check, titled “Fact-checking Alex Jones: White object on table in Macron video was tissue, not cocaine”. Euronews also investigated the allegations in its report, “Fact check: Macron, Merz and Starmer targeted by Russian ‘cocaine’ claims”.

The reports found no reliable evidence that the object was cocaine. The French government rejected the allegation, while a German government spokesperson described the claim as absurd, according to PolitiFact’s reporting.

Why did the allegation spread?

The episode illustrates how visual ambiguity can become political misinformation. A brief clip provides little context, while a suggestive caption can encourage viewers to interpret an ordinary object as evidence of wrongdoing.

Once the claim began circulating, some posts presented speculation as an established fact. The allegation was also amplified by political commentators and accounts that framed the incident as a scandal.

This does not mean that every question about a public official is illegitimate. It means that an accusation needs evidence beyond an ambiguous image.

Was Macron accused of using brain enhancers?

The viral claim concerned alleged cocaine use, not nootropics or prescription cognitive enhancers. Cocaine is a powerful stimulant with significant health risks, but it is not a safe or medically appropriate shortcut to better concentration.

There is no credible evidence in the cited reporting that Macron used cocaine during the train journey, and the incident should not be described as a verified drug scandal.

What the case establishes: Macron was the target of a viral drug allegation that fact-checkers found unsupported. It does not establish that he used illegal drugs or brain-enhancing substances.

2. Friedrich Merz: A Drug Rumour Built Around the Same Video


German Chancellor Friedrich Merz was drawn into the same controversy. Online posts claimed that the footage showed him concealing a spoon associated with drug use while Macron picked up the white object.

The allegations spread alongside the claims about Macron and Starmer. However, the footage did not provide credible evidence of cocaine use by Merz, either.

What was actually visible?

The original video showed the three leaders meeting on a train while travelling to Kyiv. A small object near Merz’s hand was interpreted by some online users as drug paraphernalia. But the claim depended on speculation rather than a verified identification of the object or evidence of drug consumption.

PolitiFact’s examination of the episode found no credible support for the allegations. Its report noted that high-resolution photographs contradicted the claim about the white object on the table and that the allegation about Merz hiding a spoon was unsupported.

The Euronews fact-check likewise described the accusations as part of a wider disinformation narrative.

Why does the distinction matter?

An accusation against a head of government can influence public opinion even if it is never substantiated. Images are particularly powerful because audiences may feel they have seen direct proof, even when the footage is ambiguous or incomplete.

This creates a serious problem for political reporting. If a journalist repeats an allegation without explaining its evidentiary weaknesses, the repetition can give the claim greater credibility than it deserves.

The appropriate approach is to examine the original footage, seek independent images, obtain relevant official responses and look for corroborating evidence. If the available evidence does not support the allegation, the report should say so clearly.

Is there evidence that Merz used nootropics?

The cited reporting does not establish that Merz used cocaine, nootropics or any other substance to improve cognitive performance. The 2025 allegation was based on the interpretation of objects in a video, not medical records, a drug test or a verified investigation demonstrating use.

Prescription medicines and performance-enhancing substances should not be conflated, either. Even if a public figure were prescribed a medicine for a legitimate medical condition, that fact alone would not establish misuse or an attempt to gain a political advantage.

What the case establishes: Merz was named in a widely circulated but unsupported drug allegation. The episode is an example of misinformation, not verified evidence of brain-enhancer use.

3. Keir Starmer: When Political Scrutiny Became a Drug Rumour


British Prime Minister Keir Starmer was the third European leader targeted by the May 2025 cocaine narrative. His presence in the train footage helped transform a claim about one object into an accusation involving three national leaders.

The episode attracted attention because the leaders were travelling together to demonstrate support for Ukraine. The online allegation therefore had implications beyond their personal reputations: it also attempted to cast doubt on a diplomatic engagement.

What did independent reporting find?

The original footage showed Starmer meeting Macron and Merz on the train. It did not establish that any of them had used cocaine.

PolitiFact’s investigation relied on higher-resolution photographs, the original video and official responses. The French presidential office identified the white object as a tissue. The fact-check found that the evidence did not support the online claim that the leaders had been caught with cocaine.

The story was also covered by Reuters, which reported the French government’s response and the spread of the allegation.

Why can allegations involving politicians become so influential?

Political figures operate in an environment where reputational attacks can spread quickly. An allegation involving illegal drugs may be used to suggest poor judgment, hypocrisy or an inability to perform official duties. But such implications cannot be established by a suggestive video alone.

A credible assessment needs to answer several separate questions:

  • Is the substance actually identifiable?
  • Is there evidence that the person used it?
  • Is there reliable information about when and where any use occurred?
  • Is there evidence of a legal violation or impairment while carrying out official responsibilities?
  • Has an investigation reached a conclusion?

These questions matter because the presence of a medicine or substance, its use, its legal status and its effects on performance are different issues.

What about cognitive enhancers?

There is no credible evidence in the cited reports that Starmer used nootropics or illegal drugs during the diplomatic journey. The viral story concerned an alleged cocaine incident, and the available evidence did not support it.

Brain-enhancing products are a separate subject. Caffeine may improve alertness temporarily, while prescription medicines such as modafinil have specific medical uses and safety limitations. Neither fact provides a basis for speculating about an individual politician’s private medical history.

What the case establishes: Starmer was included in an unsupported viral accusation. It should not be presented as a confirmed case of drug use or cognitive enhancement.

4. Volodymyr Zelenskyy: Manipulated Videos and Repeated Drug Allegations


Ukrainian President Volodymyr Zelenskyy has faced repeated claims about drug use, including allegations that he uses cocaine. Some of these claims have circulated through edited videos and manipulated images rather than credible investigative reporting.

The issue became especially visible after Russia’s full-scale invasion of Ukraine, when information about the Ukrainian leadership became a target of competing political narratives.

The 2019 drug-test episode

During Ukraine’s 2019 presidential campaign, Zelenskyy and incumbent president Petro Poroshenko became involved in a highly publicised dispute over drug testing. The episode formed part of an unconventional campaign in which the candidates challenged one another to undergo tests before a televised debate.

Reuters reported on the episode in April 2019. Contemporary reporting stated that Zelenskyy submitted a sample to a private laboratory and later published test results indicating that no narcotic substances had been found in the sample. The campaign episode was also covered by the Guardian and other news organisations.

A test result has limits: it relates to the sample, test method and time period involved. It cannot prove that a person has never used a substance at any point in their life. Equally, an allegation cannot override a reported test result without additional evidence.

The manipulated-video claims

In April 2022, videos circulated online that purported to show Zelenskyy using cocaine or endorsing it. PolitiFact investigated two of these videos and found that they had been altered.

One video appeared to show white powder on Zelenskyy’s desk during a video call. The substance had been digitally added; it was not present in the original footage. Another video rearranged parts of an interview to make it appear that Zelenskyy was describing cocaine use. In the original interview, he denied using drugs and spoke about his fondness for coffee.

The fact-check is available at PolitiFact: “Viral videos falsely claiming Ukraine’s Zelenskyy uses cocaine are altered”.

What does this reveal about political misinformation?

The Zelenskyy case demonstrates that video evidence is not automatically reliable simply because it appears to show a public figure directly. Editing, selective cuts, added objects, misleading subtitles and manipulated audio can all change the meaning of a clip.

In 2026, the same lesson applies to artificial intelligence-generated imagery and video. A convincing-looking image can be fabricated, and an authentic image can be presented with a false explanation.

Readers should look for the original footage, reputable fact-checking, independent confirmation and a clear description of what the evidence does—and does not—show.

What the case establishes: Zelenskyy has been the target of repeated drug-related allegations, and prominent viral examples were debunked as manipulated or misleading. The cited evidence does not establish that he used cocaine or brain enhancers.

5. Yanis Varoufakis: A Public Admission and a Legal Investigation in Greece


The case involving Yanis Varoufakis differs substantially from the allegations against Macron, Merz, Starmer and Zelenskyy.

Varoufakis, a Greek economist and former finance minister, publicly discussed a past experience with ecstasy during a podcast appearance. The experience, he said, took place in Sydney, Australia, in 1989. His remarks became a legal issue in Greece in early 2026 after authorities examined whether the comments could amount to promoting or encouraging drug use.

What did Varoufakis disclose?

According to reporting by Reuters and the Greek newspaper Kathimerini, Varoufakis described taking ecstasy once during his younger years. He recalled an extended period of dancing followed by a severe migraine and said that he did not take the substance again.

The admission was about an event nearly four decades earlier. It was not a disclosure that he had taken ecstasy while serving as Greece’s finance minister.

Reuters reported the development in its February 2026 article, “Greece’s ex-finance minister Varoufakis charged over use of dance drug ecstasy decades ago”. Kathimerini also reported on the preliminary investigation in January 2026.

The legal issue concerned whether his public remarks could constitute an offence related to promoting drug use. An investigation or charge must not be confused with a conviction, and the exact legal outcome should be checked against the latest court reporting before publication.

Is ecstasy a brain enhancer?

Ecstasy is the common name often used for MDMA, a psychoactive substance associated with changes in mood, perception and social experience. It is not an established, safe cognitive-enhancement treatment.

Although some people may describe feeling energetic or unusually engaged after taking a psychoactive substance, subjective experience does not establish improved memory, better judgment or safer decision-making. MDMA can also cause adverse effects, including elevated body temperature, dehydration-related complications, anxiety and other serious health problems.

Its effects are different from those of medicines prescribed for diagnosed conditions. It is misleading to place all psychoactive substances under the same label of “brain enhancers.”

What makes this case different?

Varoufakis’s account is a public admission about past drug use, not merely a rumour based on a photograph. However, the time and circumstances matter. His account concerns 1989, before his period as finance minister, and does not by itself establish that he used a substance to improve his political performance.

The legal investigation also needs to be described accurately. A prosecutor’s inquiry into public statements is not the same as an investigation proving that a public official was impaired while in office.

What the case establishes: Varoufakis publicly described taking ecstasy decades ago, and Greek authorities examined whether his remarks could violate laws concerning the promotion of drug use. It does not establish that he used nootropics or performance-enhancing drugs while in government.

What Are Brain Enhancers and Nootropics?


The phrase “brain enhancer” has no single, universally accepted medical meaning. It is commonly used to describe substances claimed to improve attention, memory, motivation, alertness or other aspects of cognition.

These products generally fall into several categories.

1. Caffeine and other familiar stimulants

Caffeine is found in coffee, tea and many energy drinks. It can temporarily increase alertness and reduce the feeling of sleepiness. Its effects depend on the dose, individual sensitivity, timing and other factors.

However, caffeine does not replace sleep, and excessive intake can contribute to anxiety, palpitations, sleep disruption and other adverse effects. Better alertness for a short period is not the same as a lasting improvement in intelligence or memory.

2. Prescription medicines

Some medicines affect attention, wakefulness or other cognitive functions. Their use depends on the condition being treated, the medicine’s approved indications and an individual’s clinical circumstances.

Modafinil, for example, is a wakefulness-promoting medicine. The European Medicines Agency’s review of modafinil recommended restricting its use to sleepiness associated with narcolepsy because of safety concerns, including psychiatric and skin reactions and potential misuse.

This is an important distinction for discussions of cognitive enhancement: a medicine may be appropriate for a diagnosed condition without being suitable for healthy people seeking a performance boost.

3. Dietary supplements marketed as nootropics

Products promoted as nootropics may contain vitamins, plant extracts, amino acids or mixtures of ingredients. Marketing claims can exceed the available evidence, and the quality of products can vary.

The label “natural” does not guarantee safety or effectiveness. A supplement may interact with medicines, contain a dose different from the one stated on the label, or include an undeclared ingredient.

A 2025 market-surveillance study published in the scientific literature examined illicit smart drugs and nootropics in European and Australian markets. Researchers identified products containing a range of substances, including prescription medicines and experimental compounds. The findings raised concerns about falsified products, adulterated supplements and substances whose health effects are poorly understood. Read the study through PubMed Central.

4. Illicit and experimental substances

Some products are sold online as research chemicals or as alternatives to established medicines. Their safety, purity and long-term effects may not have been adequately studied.

The European Union Drugs Agency’s European Drug Report 2026 describes a changing market for illicit drugs and new psychoactive substances, including compounds whose risks are not well understood. The report is not evidence that European politicians use nootropics; it provides broader context about the changing substance market and associated public-health concerns.

Do Brain Enhancers Actually Improve Political Performance?


The answer depends on the substance, the person, the dose, the task and the quality of the evidence.

A product that reduces sleepiness in someone with a diagnosed sleep disorder may improve that person’s ability to remain awake. That does not automatically mean it improves complex reasoning in a healthy individual. A stimulant may increase a person’s sense of energy while also increasing anxiety, disrupting sleep or encouraging overconfidence.

Political work involves more than sustained attention. It requires judgment, memory, emotional regulation, communication, risk assessment and the ability to weigh competing evidence. A substance that changes one aspect of alertness cannot be assumed to improve all these functions.

There is also a difference between a laboratory task and real-world leadership. A short-term change in reaction time or attention does not necessarily translate into better policy decisions, more accurate forecasts or improved diplomatic judgment.

Claims that a particular nootropic makes someone smarter should therefore be assessed against controlled human research, not testimonials or marketing language.

Are Brain-Enhancing Substances Found in Plants?


Some compounds promoted for cognitive support are derived from plants. But there is no single plant called a brain enhancer, and none of the five political cases discussed above is evidence of a plant-based cognitive enhancer being used by a European leader.

One example frequently discussed in the nootropics market is Bacopa monnieri, a creeping herb traditionally used in South Asian systems of medicine. It is sometimes marketed as “Brahmi,” although common plant names can be used inconsistently.

Bacopa typically has small, fleshy leaves and delicate flowers, often white with a pale centre. It grows in wet environments, including marshes, damp ground and the edges of ponds and streams. Its traditional use is associated with South Asia, rather than with a specific European political event or a verified European discovery site.

Some clinical studies have examined whether Bacopa extracts may affect memory or cognitive performance. However, study quality, extract composition, dose and duration vary, and the evidence does not justify treating every Bacopa product as a proven memory enhancer. It can also cause gastrointestinal side effects and may interact with medicines.

The historical and botanical details do not connect Bacopa to the five political cases in this article. Nor is there reliable evidence that this plant was used in a major European mythological event to enhance the memory or intelligence of a political leader.

This is worth stating explicitly because online articles sometimes combine unrelated themes—plants, mythology, nootropics and political scandals—to create a more dramatic story. A credible article should not invent a plant’s discovery location, attribute unsupported benefits to it, or claim that a myth proves a substance works.

If the article’s primary focus is European politicians and drug allegations, a plant’s appearance and mythology belong in a separate article about traditional medicinal plants or the history of nootropics.

How European Regulators View Cognitive Enhancers


Europe does not have one simple rule covering every product marketed as a brain enhancer. The legal status depends on whether a substance is a medicine, food supplement, controlled drug, novel food or another regulated product, as well as on the relevant country and circumstances.

Prescription medicines must meet requirements relating to quality, safety and efficacy for their authorised uses. Food supplements are regulated differently, and the fact that a product is sold legally does not establish that its cognitive-enhancement claims are clinically proven.

New psychoactive substances create additional challenges because their chemical composition and health risks may be poorly understood. The European Union Drugs Agency monitors drug markets, emerging substances and related harms. Its 2026 European Drug Report provides an up-to-date overview of European drug trends based on information reported by participating countries.

For consumers, the practical lesson is straightforward: check the ingredient list, look for reliable human studies, be wary of dramatic claims, and consult a qualified healthcare professional before using a product that could interact with a medicine or affect health.

For journalists, the lesson is equally important: regulatory concerns about a substance do not prove that a named politician uses it. Evidence about the market must not be converted into an accusation about an individual.

How to Verify Drug Allegations Against Public Officials


Political drug allegations should be assessed using the same evidence standards regardless of the person’s country, political party or position.

Start with the original source. A short social media clip may omit context. Look for the original video, full interview, official document or court record.

Check independent reporting. Reputable news organisations and fact-checkers may have access to higher-resolution images, original footage, expert analysis or official responses. A claim repeated by dozens of accounts is not necessarily supported by dozens of independent sources.

Separate allegations from findings. An investigation may establish that a claim is being examined, but it does not automatically establish guilt. A charge is not a conviction, and an admission of past behaviour is not proof of misconduct while holding office.

Consider the date and jurisdiction. Drug laws differ across countries and can change over time. A substance’s legal status in one country or year may not be the same in another.

Look for evidence of the specific claim. If the allegation concerns nootropics, evidence of cocaine use does not establish nootropic use. If the claim concerns impairment while in government, an account of behaviour decades earlier does not establish impairment during official duties.

These standards protect both public accountability and individual reputations. They also help readers identify when an article is reporting a genuine finding, describing an unresolved allegation or explaining a debunked rumour.

Conclusion: The Difference Between a Political Rumour and a Proven Finding

The five cases demonstrate why drug-related political stories require careful examination.

Emmanuel Macron, Friedrich Merz and Keir Starmer were named in a viral cocaine allegation based on an object that high-resolution photographs showed to be a tissue. Volodymyr Zelenskyy has faced drug-related misinformation, including videos that fact-checkers found had been manipulated. Yanis Varoufakis publicly described taking ecstasy in 1989 and faced a legal investigation in Greece in 2026 concerning his public remarks.

These are not five equivalent cases, and none establishes that the five figures used brain enhancers to improve their political performance.

The wider question of cognitive enhancement deserves serious attention. Prescription medicines can be valuable when used for appropriate medical reasons, while supplements and experimental substances may have uncertain benefits or meaningful risks. The growing market for products marketed as nootropics makes independent evidence, regulatory oversight and informed consumer decisions especially important.

But claims about politicians require evidence specific to the person and the allegation. A tissue is not proof of cocaine, an edited video is not a reliable confession, and a past admission is not proof of drug use while serving in government.

In political reporting, precision is not a minor technicality. It is the difference between informing the public and spreading a story that the evidence does not support.

Frequently Asked Questions

What are brain enhancers?

Brain enhancers, often called nootropics or smart drugs, are substances marketed or used to influence aspects of cognition, such as alertness, attention or memory. They include caffeine, some prescription medicines, supplements and experimental compounds. Their effectiveness and safety vary considerably.

Have five European politicians been proven to use brain enhancers?

The evidence reviewed for this article does not establish that these five political figures used nootropics to improve their performance. The cases involve debunked drug allegations, manipulated videos or a public account of historical drug use.

What happened in the 2025 cocaine allegation involving Macron, Merz and Starmer?

A video of the leaders travelling by train to Kyiv was used to suggest that they had cocaine on a table. Higher-resolution photographs showed that the white object was a tissue, and fact-checkers found no credible evidence supporting the allegation.

Why was Yanis Varoufakis investigated in 2026?

Varoufakis publicly described taking ecstasy in Australia in 1989. Greek authorities examined whether his public remarks could constitute an offence related to promoting drug use. A legal investigation should not be described as a conviction, and the latest legal status should be checked against current reporting.

Are natural nootropics safer than prescription medicines?

Not automatically. Plant-based products can cause side effects, interact with medicines or vary in composition. “Natural” is not a guarantee of safety, and a supplement’s presence on the market does not prove its cognitive benefits.

Does modafinil improve intelligence?

Modafinil is a wakefulness-promoting medicine authorised for specific medical uses. It should not be treated as a general-purpose intelligence enhancer. Its risks and appropriate use should be assessed with a qualified healthcare professional.

Can plants such as Bacopa improve memory?

Some studies have examined Bacopa extracts for possible effects on memory and cognition, but the evidence varies by product, extract, dose and study design. It should not be described as a guaranteed or universally proven brain enhancer.

How can readers identify false drug allegations about politicians?

Check original footage and documents, consult independent fact-checkers, seek corroboration from reputable reporting, and distinguish allegations from confirmed findings. Avoid drawing conclusions from ambiguous images, edited videos or anonymous social media claims.